were examined. Blood clearance of 59Fe, 59Fe incorporation into circulating erythrocytes, and tissue distribution of 59Fe were also studied.
MATERIAL AND METHODS
(1) Animals Male 14 week old CF#1/Nrs mice, weighing 30-35 g, were used for the experiments. Each experimental group consisted of 6 to 8 mice. In the colony forming units assay, 11 mice per group were used as the recipient.
(2) Plutonium Polymeric plutonium (1.67 aCi plutonium-239 per milliliter) was freshly prepared from the stock solution of Pu(N03), by careful dropwise addition of 0.01% sodium citrate and 1N NaOH to pH 8 with molar plutonium : citrate ratio of 2. Within one hour after preparation, a single intravenous injection of polymeric plutonium-239 was given to the mice at the dose level of 5 iCi/kg, 10 ,uCi/kg and 15 pCi/kg of body weight.
Tissue distribution of intravenously injected polymeric plutonium in mice and average dose rate to the femoral marrow, spleen and liver were previously reported').
(3) Nucleated cell counts and in vivo colony forming units assay.
At 28 and 56 days after injection of polymeric plutonium, the number of nucleated cells and CFUs per femoral marrow were examined by the method of Till et al.s'. Firstly, marrow cell suspensions in Hank's solution were obtained and nucleated cell counts were made in a hemocytometer.
And then cell suspensions were tested for their ability to produce CFUs in recipient mice. During the afternoon of the day prior to the injection of the marrow cells, the mice to be injected with bone marrow cells were given 800R whole body X-irradiation.
The recipient mice were intravenously in jected with 105 nucleated bone marrow cells from the plutonium injected or the control mice. The irradiated recipient mice were observed for 10 days. Survivors were sacri ficed on the 10th day and nodules in the spleen of the recipients were counted.
(4) Blood clearance of 59Fe, "Fe incorporation into circulating erythrocytes and tissue distribution of 59Fe.
At 28 and 56 days after injection of polymeric plutonium, mice were intravenously given a dose of 1 pCi of 59Fe as ferrous citrate. At 2, 30, 60, 90 and 120 minutes, subsequent blood sample (25 p1) was drawn from retroorbital venous plexus by micro hematocrit tube. As direct uptake of plasma iron into immature erythrocyte (reticulo cyte) in the circulation is considered to be very small", blood clearance of "Fe was measured instead of plasma clearance of 59Fe. At 24 hours after injection of 59Fe, blood samples were taken from inferior vena cava of ether-anesthetized mice as much as possible. The method employed to determine the percentage 59Fe uptake into cir culating erythrocytes is that described by Hodgson' . Briefly, 0.5 ml of blood sample were washed with saline and then radioactivity in the cells were counted in a well type scintillation counter. The radioactivity in the cells was compared to that of the solution injected. The percentage uptake of tracer in erythrocytes was calculated by using the previously reported blood volume data".
After exsanguination, the liver, spleen and femur were excised and weighed. The radioactivity of each sample was determined in a well type scintillation counter.
Experimental values were expressed as mean and standard error of the mean for each group. Statistical evaluations were done by t tests for experimental and control groups of the same experiment. 
RESULTS
A progressive decrease in the number of nucleated cells was observed when the amount of polymeric plutonium injected was increased from 5,uCi/kg to 15 1Ci/kg (Fig. 1) . The number of nucleated cells was reduced to one-third of the control at 56 days after injection of 15,uCi/kg of plutonium.
Intravenous injection of polymeric plutonium was found to reduce the number of CFUs per 105 nucleated cells (Fig. 2) . The number of colonies formed in the spleen of the recipient was about 10.7 when 105 nucleated cells had been transfused from normal donor, The decrease in the number of CFUs per 105 nucleated cells was not so great when nucleated cells had been prepared and injected into the recipient at 28 days after injection of polymeric plutonium.
For example, the number of CFUs per 105 nucleated cells was 7.9 when the donor had been injected with 15 1cCi/kg of polymeric plutonium. On the other hand, the decrease in the number of CFUs per 105 nucleated cells was significant (p<0.01) when nucleated cells had been prepared and injected to the recipient at 56 days after injection of 10 and 15 iCi/kg of polymeric plutonium.
105 nucleated cells obtained from the donor which had been injected with 15 pCi/kg of polymeric plutonium produced only 1.4 CFUs. Changes in the number of CFUs per femoral marrow are shown in Fig. 3 . Even at 28 days after injection of 5 pCi/kg, the number of CFUs per femoral marrow de creased significantly (p<0.01).
The decrease of CFUs per femur against increasing dose of plutonium was observed. At 56 days after injection of 5, 10 and 15 pCi/kg of plutonium, about 70, 37 and 4% of the control value were observed, respectively. After injection of 15 [tCi/kg, the decrease in the number of CFUs per femoral marrow was significantly (p<0.01) greater at 56 days than at 28 days.
At 28 and 56 days after injection of 10 pCi/kg, the decrease was almost the same. In the case of 5 pCi/kg, statistical evaluation indicated that the number of CFUs per femoral marrow at 28 days did not significantly differ from those at 56 days.
The disappearance of "Fe from the circulation at 56 days after injection of poly meric plutonium is shown in Fig. 4 . No significant change in disappearance of "Fe was observed with the exception of one group. At 56 days after injection of 151tCi/kg, the pattern of blood clearance of 59Fe was very different from control. At 2 minutes after injection of 59Fe, activity in the blood was less than one half of the control, which decreased very slowly thereafter. At 28 days after injection of polymeric plutonium, 10 and 15 pCi/kg of plutonium produced the decrease in incorporation of 59Fe into circulating erythrocytes, while 5 pCi/kg of plutonium produced no significant decrease. But almost the same amount of 59Fe was incorporated into circulating erythrocytes when 10 and 15 pCi/kg of plutonium were injected. On the other hand, at 56 days after injection of plutonium, 15 pCi/kg produced greater decrease in "Fe uptake than 10 pCi/kg, and 5,uCi/kg of plutonium also produced a decrease.
The changes in tissue distribution of "Fe after injection of plutonium are shown in Fig. 6 . The uptake of 59Fe by the liver was almost within the normal range except for one group. Hepatic uptake of "Fe increased at 56 days after injection of 15 pCi/kg of plutonium.
The uptake of "Fe by the liver of this group was almost three times of the control value. 10 pCi/kg of plutonium seemed to be the most effective in reduc ing the uptake of 59Fe by the spleen. When 15 pCi/kg of plutonium had been injected, the reduction was similar to the 5,uCi/kg group. But the uptake of 59Fe by the spleen was somewhat scattered, and statistical analysis indicated no significant difference among all of the experimental groups. Except for 56 days after injection of 15 pCi/kg, the uptake of 59Fe by the femur significantly increased in proportion to the administered dose of plutonium.
But, at 56 days after injection of 15,uCi/kg, 59Fe uptake by the femur was similar to the control group. 
DISCUSSION
The hematopoietic activity expressed as the number of nucleated cells","' decreased in proportion to the amount of plutonium injected. The number of CFUs per 105 nucleated cells were significantly reduced only at 56 days after injection of 10 and 15,uCi/kg of plutonium.
Therefore, it may be reasonable to consider that fairly large amount of radiation dose is necessarily to reduce CFUs per 105 nucleated cells. Number of CFUs in the femoral marrow also decreased when the amount of plutonium admini stered increased.
These results of nucleated cell counts and in vivo colony forming units assay indicate that the hematopoietic function of the bone marrow is depressed by polymeric plutonium of 5,uCi/kg or more.
59Fe uptake into circulating erythrocytes gives a measure of effective erythropoiesis .
On the other hand, the presence of a significant proportion of nonheme iron in the bone marrow and spleen implies that care must be taken when interpreting the results of 59Fe uptake into the bone marrow and spleen in terms of erythropoiesis.
As the circulating blood volume in the organ also contributes to the uptake of 59Fe activity, blood was withdrawn as much as possible in this experiment.
At 56 days after injection of the highest dose, very different pattern of blood 59Fe clearance was observed. As previously reported", the blood volume measured with 51Cr method in this group was almost at the normal level . A's the same amount of 59Fe was intravenously injected in all experimental groups , smaller activity of 59Fe in the blood of this group indicated very rapid disappearance of "Fe within 2 minutes. The exact reason for the very rapid disappearance of 59Fe in this group is not clear, but increased hepatic uptake of 59Fe indicates that rapid uptake by the liver may be one reason.
Incorporation of 59Fe into circulating erythrocytes was reduced after injection of plutonium.
Since the 24 hours 59Fe utilization study measures mainly the radioiron taken up by reticulocytes12', this fact indicates that the number of these cells in the erythropoietic system is reduced by polymeric plutonium. At 56 days after injection of plutonium, correlation could be observed between the reduction of 59Fe incorporation into erythrocytes and the dose of plutonium. But no clear correlation could be observed at 28 days. The effect of plutonium on hematopoietic tissue depends on the injury to the hematopoietic tissue itself, and also on the recovery of the hematopoietic tissue"'. Therefore, simple dose effect relationship may not be expected, especially, when the recovery exists.
Increased hepatic uptake of 59Fe was observed at 56 days after injection of the highest dose. Because of greatly depressed erythropoiesis by plutonium, excess 59Fe might be deposited in the liver as storage iron.
59Fe uptake into the spleen was the smallest when intermediate dose of plutonium was injected. This specific retention of 59Fe in the spleen was considered to be the result of ill balanced uptake of 59Fe. 59Fe uptake into splenic heme fraction might decrease when the amount of plutonium in the spleen increased. On the other hand, because of depressed erythropoiesis, excess iron may be taken up into iron store of the spleen with increasing amount of plutonium injected.
Therefore, 59Fe uptake in the spleen may be the combined results of decreased erythropoiesis and increased iron store. This may be one reason why the intermediate dose of plutonium induced the smallest total uptake of "Fe in the spleen. Because of ill balanced uptake of 59Fe, the amount of 59Fe in the spleen might become so scattered.
Except for the group at 56 days after injection of the highest dose of plutonium, 59Fe in the femur increased in proportion to the injected dose of plutonium . Increased 59Fe uptake in the femur indicates the next three possibilities .
(1) Erythropoietic activity in the femoral marrow increases.
(2) 59Fe taken into iron stores increases because of decreased erythropoiesis.
(3) Because of increased destruction of immature erythrocytes in the marrow, 59Fe in the femur increases. The blood clearance of 59Fe remained almost the same as in the control except for the highest dose group, and increased hematopoietic activity was not observed in the nucleated cell counts, in vivo colony forming units assay and previously reported hematological determinations'. Therefore, there is little chance for the first possibility.
As could be seen in the liver, excess iron might be deposited in the femur as storage iron because of decreased erythropoiesis by plutonium. Therefore, there is a chance for the second possibility. Next, we would like to refer to the third possibility, ineffective erythropoiesis.
Inef fective erythropoiesis, a term originally applied by Giblett et a1.111, connotes the early destruction of erythrocytes either within the marrow or shortly after the cells reach the peripheral blood. Under ineffective erythropoiesis the blood clearance of 59Fe is normal or accelerated, and 59Fe incorporation into circulating erythrocytes is depressed. Furthermore, 59Fe in the bone marrow may increase because of increased destruction of immature erythrocytes in the marrow. Plutonium injected mice in this experiment had some similarities to ineffective erythropoiesis.
The shortened erythrocyte life span by polymeric plutonium" also indicates the possibility of ineffective erythropoiesis.
In the highest dosage group, the decreased erythropoiesis might be so great that excess iron might be deposited in the liver as storage iron, and the tendency of ineffective erythropoiesis might be very small. In dogs injured by subacute doses of monomeric plutonium, bone marrow biopsies showed polychromatophilic and oxyphilic erythroblasts with pyknosis and fragmentation of the nuclei, and erythrocyte with Dolly's bodies and basophilic punctuation"'.
These facts also indicate the possibility of ineffective erythro poiesis by plutonium. Bone marrow biopsies, measurement of plasma iron, plasma iron turnover and chemical separation to measure iron uptake into the heme and nonheme fraction of the tissues may enable more reliable considerations of ineffective erythro poiesis.
As previously reported", the results of the various examinations made for hema tological determination such as erythrocyte counts, hematocrit, hemoglobin concentration and reticulocyte counts indicated that anemia was not induced by 5 ,uCi/kg of polymeric plutonium.
From the results of present study, we may conclude that the hematological activity in the bone marrow is disturbed by the dose as low as 5 PCi/kg, with which clinically detectable anemia are not induced.
